Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone).
Vogel
Victor G
VG
American Cancer Society, Atlanta, GA 30303, USA. victor.vogel@cancer.org